Join
Live feed
·
INSIDERFilingvia Quantisnow
Corbus Pharmaceuticals Holdings Inc. logo

Chief Executive Officer Cohen Yuval sold $171,396 worth of shares (17,000 units at $10.08) as part of a pre-agreed trading plan, decreasing direct ownership by 10% to 157,316 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
CRBP· Corbus Pharmaceuticals Holdings Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track CRBP (Corbus Pharmaceuticals Holdings Inc.) and more on Quantisnow.